Are RGEN insiders buying or selling?

Over the last 90 days, RGEN insiders were net sellers, reporting $0.00 of open-market purchases and $5,953,261 of sales.

When was the last RGEN insider purchase?

No open-market insider purchase of Repligen Corp. stock was reported in the last 90 days.

Watch Insiders reads the SEC Form 4 filings that Repligen Corp. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

RGENHealthcare

In the last 90 days, 1 Repligen Corp. (RGEN) insider reported no open-market purchases and 5 sales totaling $5,953,261. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

Executive filings

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Oct 5, 2026	Olivier Loeillot	Chief Executive Officer	Sale	5,535	$187.29	$1,036,654
Sep 24, 2026	Olivier Loeillot	Chief Executive Officer	Sale	12,946	$190.00	$2,459,740
Sep 21, 2026	Olivier Loeillot	Chief Executive Officer	Sale	5,426	$180.00	$976,680
Sep 4, 2026	Olivier Loeillot	Chief Executive Officer	Sale	3,035	$165.90	$503,507
Aug 20, 2026	Olivier Loeillot	Chief Executive Officer	Sale	5,426	$180.00	$976,680
Jul 16, 2026	Jason K Garland	CFO	Sale	530	$150.00	$79,500
Jun 25, 2026	Jason K Garland	CFO	Sale	733	$145.00	$106,285
Apr 21, 2026	Olivier Loeillot	Chief Executive Officer	Sale	3,832	$140.00	$536,480

Common questions

Are RGEN insiders buying or selling?: Over the last 90 days, RGEN insiders were net sellers, reporting $0.00 of open-market purchases and $5,953,261 of sales.
When was the last RGEN insider purchase?: No open-market insider purchase of Repligen Corp. stock was reported in the last 90 days.
Where does RGEN insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Repligen Corp. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

Healthcare